Literature DB >> 21084919

PROFILE PD: profile of function and impairment level experience with Parkinson disease--clinimetric properties of a rating scale for physical therapist practice.

Margaret Schenkman1, Kimberly McFann, Anna E Barón.   

Abstract

BACKGROUND AND
PURPOSE: Individuals with Parkinson disease (PD) experience a range of deficits of body systems and activities. A clinical test is needed that is reliable, valid, applicable to physical therapist practice, and appropriate for use in early and mid-stages of the disease. PROFILE PD is one such scale, consisting of 24 items that would typically be assessed during the physical therapist's examination and evaluation of individuals with PD. The purpose of this article is to report on clinimetric properties of the PROFILE PD and to make the test available for use.
METHODS: Interrater reliability was determined using the intraclass correlation coefficient. Construct validity was determined by comparing scores on the PROFILE PD with the gold standard (Unified Parkinson's Disease Rating Scale [UPDRS]) as well as scales of physical activity and participation. Construct validity and structure of the PROFILE PD were further examined using exploratory factor analysis using principal component analysis with Promax rotation that allows a correlated factor structure.
RESULTS: Interrater reliability of the PROFILE PD was high (ICC = 0.97). Construct validity was demonstrated with the UPDRS (r = 0.86, P < 0.0001), Schwab & England Activities of Daily Living Scale (S&E) (r = -0.83, P < 0.0001), and Continuous Scale Physical Functional Performance test (r = -0.62, P < 0.0001). Principal component analysis demonstrated that the test comprises a single scale.
CONCLUSIONS: The PROFILE PD is a reliable and valid scale that can be used to quantify alterations in body systems and activity of individuals in early and mid-stages of PD. Use of the scale can provide an overall summary of the impact of PD on body systems and activities.

Entities:  

Mesh:

Year:  2010        PMID: 21084919      PMCID: PMC3014090          DOI: 10.1097/NPT.0b013e3181fd1b8d

Source DB:  PubMed          Journal:  J Neurol Phys Ther        ISSN: 1557-0576            Impact factor:   3.649


  13 in total

1.  Development of a clinical rating scale for persons with Parkinson's disease.

Authors:  T M Cutson; R Sloane; M Schenkman
Journal:  J Am Geriatr Soc       Date:  1999-06       Impact factor: 5.562

2.  A method for evaluating disability in patients with Parkinson's disease.

Authors:  G J CANTER; R DE LA TORRE; M MIER
Journal:  J Nerv Ment Dis       Date:  1961-08       Impact factor: 2.254

3.  Evaluation of Parkinson's disease: reliability of three rating scales.

Authors:  A Ginanneschi; F Degl'Innocenti; S Magnolfi; M T Maurello; L Catarzi; P Marini; L Amaducci
Journal:  Neuroepidemiology       Date:  1988       Impact factor: 3.282

4.  Exercise: effects on physical functional performance in independent older adults.

Authors:  M E Cress; D M Buchner; K A Questad; P C Esselman; B J deLateur; R S Schwartz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1999-05       Impact factor: 6.053

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Parkinson's Disease Society Brain Bank, London: overview and research.

Authors:  S E Daniel; A J Lees
Journal:  J Neural Transm Suppl       Date:  1993

7.  Systematic evaluation of rating scales for impairment and disability in Parkinson's disease.

Authors:  Claudia Ramaker; Johan Marinus; Anne Margarethe Stiggelbout; Bob Johannes Van Hilten
Journal:  Mov Disord       Date:  2002-09       Impact factor: 10.338

Review 8.  The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations.

Authors: 
Journal:  Mov Disord       Date:  2003-07       Impact factor: 10.338

9.  Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.

Authors:  Andrew Siderowf; Michael McDermott; Karl Kieburtz; Karen Blindauer; Sandra Plumb; Ira Shoulson
Journal:  Mov Disord       Date:  2002-07       Impact factor: 10.338

10.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Authors:  Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.